Pan J - Search Results

1

Ponatinib induces apoptosis in imatinib-resistant human mast cells by dephosphorylating mutant D816V KIT and silencing β-catenin signaling.

Jin B, Ding K, Pan J. Jin B, et al. Among authors: pan j. Mol Cancer Ther. 2014 May;13(5):1217-30. doi: 10.1158/1535-7163.MCT-13-0397. Epub 2014 Feb 19. Mol Cancer Ther. 2014. PMID: 24552773

2

Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.

Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, Lu Z, Chen Q, Lai Y, Pan J. Shi X, et al. Among authors: pan j. Clin Cancer Res. 2009 Mar 1;15(5):1686-97. doi: 10.1158/1078-0432.CCR-08-2141. Epub 2009 Feb 24. Clin Cancer Res. 2009. PMID: 19240172

3

Activity of triptolide against human mast cells harboring the kinase domain mutant KIT.

Jin Y, Chen Q, Shi X, Lu Z, Cheng C, Lai Y, Zheng Q, Pan J. Jin Y, et al. Among authors: pan j. Cancer Sci. 2009 Jul;100(7):1335-43. doi: 10.1111/j.1349-7006.2009.01159.x. Epub 2009 Apr 3. Cancer Sci. 2009. PMID: 19383029 Free PMC article.

4

Triptolide abrogates oncogene FIP1L1-PDGFRalpha addiction and induces apoptosis in hypereosinophilic syndrome.

Jin Y, Chen Q, Lu Z, Chen B, Pan J. Jin Y, et al. Among authors: pan j. Cancer Sci. 2009 Nov;100(11):2210-7. doi: 10.1111/j.1349-7006.2009.01283.x. Epub 2009 Jul 9. Cancer Sci. 2009. PMID: 19671059 Free PMC article.

5

Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation.

Lu Z, Jin Y, Qiu L, Lai Y, Pan J. Lu Z, et al. Among authors: pan j. Cancer Lett. 2010 Apr 28;290(2):182-91. doi: 10.1016/j.canlet.2009.09.006. Epub 2009 Oct 12. Cancer Lett. 2010. PMID: 19819619

6

Triptolide inhibits Jak2 transcription and induces apoptosis in human myeloproliferative disorder cells bearing Jak2V617F through caspase-3-mediated cleavage of Mcl-1.

Chen Q, Lu Z, Jin Y, Wu Y, Pan J. Chen Q, et al. Among authors: pan j. Cancer Lett. 2010 May 28;291(2):246-55. doi: 10.1016/j.canlet.2009.10.019. Epub 2009 Nov 25. Cancer Lett. 2010. PMID: 19942343

7

The antitumor activity of homoharringtonine against human mast cells harboring the KIT D816V mutation.

Jin Y, Lu Z, Cao K, Zhu Y, Chen Q, Zhu F, Qian C, Pan J. Jin Y, et al. Among authors: pan j. Mol Cancer Ther. 2010 Jan;9(1):211-23. doi: 10.1158/1535-7163.MCT-09-0468. Epub 2010 Jan 6. Mol Cancer Ther. 2010. PMID: 20053766

8

Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives: Antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-Abl.

Xu F, Shi X, Li S, Cui J, Lu Z, Jin Y, Lin Y, Pang J, Pan J. Xu F, et al. Among authors: pan j. Bioorg Med Chem. 2010 Mar 1;18(5):1806-15. doi: 10.1016/j.bmc.2010.01.052. Epub 2010 Jan 25. Bioorg Med Chem. 2010. PMID: 20149665

9

The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells.

Pan J, Cheng C, Verstovsek S, Chen Q, Jin Y, Cao Q. Pan J, et al. Cancer Lett. 2010 Jul 28;293(2):167-74. doi: 10.1016/j.canlet.2010.01.006. Epub 2010 Feb 13. Cancer Lett. 2010. PMID: 20153924

10

GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells.

Shi X, Wang D, Ding K, Lu Z, Jin Y, Zhang J, Pan J. Shi X, et al. Among authors: pan j. Cancer Biol Ther. 2010 Apr 15;9(8):640-50. doi: 10.4161/cbt.9.8.11269. Epub 2010 Apr 20. Cancer Biol Ther. 2010. PMID: 20160501 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,971 results

Search Page

Filters